Importance of dose intensity in neuro-oncology clinical trials: Summary Report of the Sixth Annual Meeting of the Blood-Brain Barrier Disruption Consortium

Nancy D. Doolittle, Clarke P. Anderson, W. Archie Bleyer, J. Gregory Cairncross, Timothy Cloughesy, Stephen L. Eck, Paul Guastadisegni, Walter A. Hall, Leslie L. Muldoon, Sunil J. Patel, David Peereboom, Tali Siegal, Edward A. Neuwelt

Research output: Contribution to journalArticlepeer-review

26 Scopus citations

Fingerprint

Dive into the research topics of 'Importance of dose intensity in neuro-oncology clinical trials: Summary Report of the Sixth Annual Meeting of the Blood-Brain Barrier Disruption Consortium'. Together they form a unique fingerprint.

Medicine & Life Sciences